@investwithgigi: Politician Ro Khanna bought Moderna right before it jumped 170%, and he’s just bought this $20 pharma stock. But here’s what’s interesting: both trades happened through his family trust according to financial disclosures. The stock is Amneal Pharmaceuticals. While most of Wall Street is distracted by its recent FDA approval for a complex injection, they are completely missing its massive biosimilar expansion. Over 100 major biologic drugs are losing patent exclusivity over the coming decade, opening a staggering $300 billion market gap. While typical generic drug companies get crushed by brutal price wars, Amneal closed a $750 million buyout of Kashiv BioSciences to build a dominant empire in biosimilars. They’ve quietly posted consecutive years of growth and are targeting over $4 billion in revenue by the end of the decade. Now, the stock ran up over 100% this past year, and insiders have been selling into strength. Instead of blindly buying right now, I’m watching two specific items in the Form 10-Q filing and the Q3 earnings in October. I’ll post an update if the news is positive. Follow if you want to invest in what Ro Khanna is buying. Not financial advice. Always do your research before investing.
